AURKA and non-small cell lung carcinoma: Furthermore, it was demonstrated that up-regulating the expression of miR-32 via administration of tanshinone, could suppress AURKA expression leading to inhibition of Non-Small Cell Lung Cancer (NSCLC) [49].